eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Study of unilateral retinoblastoma with and without histopathologic high-risk features and the role of adjuvant chemotherapy

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
  3. Intervention
  4. Intervention
    Vincristine sulfate
  5. Additional Topic(s)
    Antineoplastic combined chemotherapy protocols
  6. Resource Description
    This phase III trial is studying vincristine, carboplatin, and etoposide to see how well they work compared to observation only in treating patients who have undergone surgery for newly diagnosed retinoblastoma.
  7. Contact
    Berenberg, Jeffrey
  8. PI
    Wilkinson, Robert, M.D.
  9. Topic
    connective tissue cancer
  10. Study Population
    Males and females up to age 6 with retinoblastoma in one eye only, no more than 4 weeks since surgery to remove the eye, and no previous chemotherapy.
  11. Website(s)
  12. Funded by
    Children's Oncology Group
  13. Phase
    Phase 3 clinical trial
  14. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016